Recruitment of young adult cancer survivors into a randomized controlled trial of an mHealth physical activity intervention
Purpose Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled t...
Saved in:
| Published in | Current controlled trials in cardiovascular medicine Vol. 23; no. 1; pp. 254 - 13 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
04.04.2022
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1745-6215 1745-6215 |
| DOI | 10.1186/s13063-022-06148-5 |
Cover
| Abstract | Purpose
Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled trial of a mobile physical activity intervention for YACS.
Methods
We conducted formative work to guide development of recruitment messages and used a variety of methods and channels to recruit posttreatment YACS (diagnosed ages 18–39, participating in < 150 min/week of moderate-to-vigorous intensity activity). We used targeted social media advertisements, direct mailings, clinical referrals, and phone calls to potentially eligible individuals identified through local tumor registries. We also asked community organizations to share study information and advertized at a national conference for YACS.
Results
The final sample of 280 participants (23% identified as racial/ethnic minority individuals, 18% male, mean 33.4 ± 4.8 years) was recruited over a 14-month period. About 38% of those who completed initial screening online (
n
= 684) or via telephone (
n
= 63) were randomized. The top recruitment approach was unpaid social media, primarily via Facebook posts by organizations/friends (45%), while direct mail yielded 40.7% of participants. Other social media (paid advertisements, Twitter), email, clinic referrals, and conference advertisements each yielded 3% or fewer participants. The most cost-effective methods per participant recruited were unpaid social media posts and direct mailings.
Conclusions
The IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS.
Trial registration
ClinicalTrials.gov
NCT03569605
. Registered on 26 June 2018. |
|---|---|
| AbstractList | Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled trial of a mobile physical activity intervention for YACS.PURPOSEFew studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled trial of a mobile physical activity intervention for YACS.We conducted formative work to guide development of recruitment messages and used a variety of methods and channels to recruit posttreatment YACS (diagnosed ages 18-39, participating in < 150 min/week of moderate-to-vigorous intensity activity). We used targeted social media advertisements, direct mailings, clinical referrals, and phone calls to potentially eligible individuals identified through local tumor registries. We also asked community organizations to share study information and advertized at a national conference for YACS.METHODSWe conducted formative work to guide development of recruitment messages and used a variety of methods and channels to recruit posttreatment YACS (diagnosed ages 18-39, participating in < 150 min/week of moderate-to-vigorous intensity activity). We used targeted social media advertisements, direct mailings, clinical referrals, and phone calls to potentially eligible individuals identified through local tumor registries. We also asked community organizations to share study information and advertized at a national conference for YACS.The final sample of 280 participants (23% identified as racial/ethnic minority individuals, 18% male, mean 33.4 ± 4.8 years) was recruited over a 14-month period. About 38% of those who completed initial screening online (n = 684) or via telephone (n = 63) were randomized. The top recruitment approach was unpaid social media, primarily via Facebook posts by organizations/friends (45%), while direct mail yielded 40.7% of participants. Other social media (paid advertisements, Twitter), email, clinic referrals, and conference advertisements each yielded 3% or fewer participants. The most cost-effective methods per participant recruited were unpaid social media posts and direct mailings.RESULTSThe final sample of 280 participants (23% identified as racial/ethnic minority individuals, 18% male, mean 33.4 ± 4.8 years) was recruited over a 14-month period. About 38% of those who completed initial screening online (n = 684) or via telephone (n = 63) were randomized. The top recruitment approach was unpaid social media, primarily via Facebook posts by organizations/friends (45%), while direct mail yielded 40.7% of participants. Other social media (paid advertisements, Twitter), email, clinic referrals, and conference advertisements each yielded 3% or fewer participants. The most cost-effective methods per participant recruited were unpaid social media posts and direct mailings.The IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS.CONCLUSIONSThe IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS.ClinicalTrials.gov NCT03569605 . Registered on 26 June 2018.TRIAL REGISTRATIONClinicalTrials.gov NCT03569605 . Registered on 26 June 2018. PurposeFew studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled trial of a mobile physical activity intervention for YACS.MethodsWe conducted formative work to guide development of recruitment messages and used a variety of methods and channels to recruit posttreatment YACS (diagnosed ages 18–39, participating in < 150 min/week of moderate-to-vigorous intensity activity). We used targeted social media advertisements, direct mailings, clinical referrals, and phone calls to potentially eligible individuals identified through local tumor registries. We also asked community organizations to share study information and advertized at a national conference for YACS.ResultsThe final sample of 280 participants (23% identified as racial/ethnic minority individuals, 18% male, mean 33.4 ± 4.8 years) was recruited over a 14-month period. About 38% of those who completed initial screening online (n = 684) or via telephone (n = 63) were randomized. The top recruitment approach was unpaid social media, primarily via Facebook posts by organizations/friends (45%), while direct mail yielded 40.7% of participants. Other social media (paid advertisements, Twitter), email, clinic referrals, and conference advertisements each yielded 3% or fewer participants. The most cost-effective methods per participant recruited were unpaid social media posts and direct mailings.ConclusionsThe IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS.Trial registrationClinicalTrials.govNCT03569605. Registered on 26 June 2018. Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled trial of a mobile physical activity intervention for YACS. We conducted formative work to guide development of recruitment messages and used a variety of methods and channels to recruit posttreatment YACS (diagnosed ages 18-39, participating in < 150 min/week of moderate-to-vigorous intensity activity). We used targeted social media advertisements, direct mailings, clinical referrals, and phone calls to potentially eligible individuals identified through local tumor registries. We also asked community organizations to share study information and advertized at a national conference for YACS. The final sample of 280 participants (23% identified as racial/ethnic minority individuals, 18% male, mean 33.4 ± 4.8 years) was recruited over a 14-month period. About 38% of those who completed initial screening online (n = 684) or via telephone (n = 63) were randomized. The top recruitment approach was unpaid social media, primarily via Facebook posts by organizations/friends (45%), while direct mail yielded 40.7% of participants. Other social media (paid advertisements, Twitter), email, clinic referrals, and conference advertisements each yielded 3% or fewer participants. The most cost-effective methods per participant recruited were unpaid social media posts and direct mailings. The IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS. ClinicalTrials.gov NCT03569605 . Registered on 26 June 2018. Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled trial of a mobile physical activity intervention for YACS. We conducted formative work to guide development of recruitment messages and used a variety of methods and channels to recruit posttreatment YACS (diagnosed ages 18-39, participating in < 150 min/week of moderate-to-vigorous intensity activity). We used targeted social media advertisements, direct mailings, clinical referrals, and phone calls to potentially eligible individuals identified through local tumor registries. We also asked community organizations to share study information and advertized at a national conference for YACS. The final sample of 280 participants (23% identified as racial/ethnic minority individuals, 18% male, mean 33.4 [+ or -] 4.8 years) was recruited over a 14-month period. About 38% of those who completed initial screening online (n = 684) or via telephone (n = 63) were randomized. The top recruitment approach was unpaid social media, primarily via Facebook posts by organizations/friends (45%), while direct mail yielded 40.7% of participants. Other social media (paid advertisements, Twitter), email, clinic referrals, and conference advertisements each yielded 3% or fewer participants. The most cost-effective methods per participant recruited were unpaid social media posts and direct mailings. The IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS. Abstract Purpose Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled trial of a mobile physical activity intervention for YACS. Methods We conducted formative work to guide development of recruitment messages and used a variety of methods and channels to recruit posttreatment YACS (diagnosed ages 18–39, participating in < 150 min/week of moderate-to-vigorous intensity activity). We used targeted social media advertisements, direct mailings, clinical referrals, and phone calls to potentially eligible individuals identified through local tumor registries. We also asked community organizations to share study information and advertized at a national conference for YACS. Results The final sample of 280 participants (23% identified as racial/ethnic minority individuals, 18% male, mean 33.4 ± 4.8 years) was recruited over a 14-month period. About 38% of those who completed initial screening online (n = 684) or via telephone (n = 63) were randomized. The top recruitment approach was unpaid social media, primarily via Facebook posts by organizations/friends (45%), while direct mail yielded 40.7% of participants. Other social media (paid advertisements, Twitter), email, clinic referrals, and conference advertisements each yielded 3% or fewer participants. The most cost-effective methods per participant recruited were unpaid social media posts and direct mailings. Conclusions The IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS. Trial registration ClinicalTrials.gov NCT03569605 . Registered on 26 June 2018. Purpose Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled trial of a mobile physical activity intervention for YACS. Methods We conducted formative work to guide development of recruitment messages and used a variety of methods and channels to recruit posttreatment YACS (diagnosed ages 18-39, participating in < 150 min/week of moderate-to-vigorous intensity activity). We used targeted social media advertisements, direct mailings, clinical referrals, and phone calls to potentially eligible individuals identified through local tumor registries. We also asked community organizations to share study information and advertized at a national conference for YACS. Results The final sample of 280 participants (23% identified as racial/ethnic minority individuals, 18% male, mean 33.4 [+ or -] 4.8 years) was recruited over a 14-month period. About 38% of those who completed initial screening online (n = 684) or via telephone (n = 63) were randomized. The top recruitment approach was unpaid social media, primarily via Facebook posts by organizations/friends (45%), while direct mail yielded 40.7% of participants. Other social media (paid advertisements, Twitter), email, clinic referrals, and conference advertisements each yielded 3% or fewer participants. The most cost-effective methods per participant recruited were unpaid social media posts and direct mailings. Conclusions The IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS. Trial registration ClinicalTrials.govNCT03569605. Registered on 26 June 2018. Keywords: Young adults, Cancer survivors, Physical activity, Recruitment methods, Social media, Cost Purpose Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes recruitment strategies used in the IMproving Physical Activity after Cancer Treatment (IMPACT) study, a 12-month randomized controlled trial of a mobile physical activity intervention for YACS. Methods We conducted formative work to guide development of recruitment messages and used a variety of methods and channels to recruit posttreatment YACS (diagnosed ages 18–39, participating in < 150 min/week of moderate-to-vigorous intensity activity). We used targeted social media advertisements, direct mailings, clinical referrals, and phone calls to potentially eligible individuals identified through local tumor registries. We also asked community organizations to share study information and advertized at a national conference for YACS. Results The final sample of 280 participants (23% identified as racial/ethnic minority individuals, 18% male, mean 33.4 ± 4.8 years) was recruited over a 14-month period. About 38% of those who completed initial screening online ( n = 684) or via telephone ( n = 63) were randomized. The top recruitment approach was unpaid social media, primarily via Facebook posts by organizations/friends (45%), while direct mail yielded 40.7% of participants. Other social media (paid advertisements, Twitter), email, clinic referrals, and conference advertisements each yielded 3% or fewer participants. The most cost-effective methods per participant recruited were unpaid social media posts and direct mailings. Conclusions The IMPACT trial successfully met enrollment goals using a national strategy to recruit physically inactive YACS. Our approaches can inform recruitment planning for other remotely-delivered intervention trials enrolling YACS. Trial registration ClinicalTrials.gov NCT03569605 . Registered on 26 June 2018. |
| ArticleNumber | 254 |
| Audience | Academic |
| Author | Valle, Carmina G. LaRose, Jessica Gokee Nezami, Brooke T. Camp, Lindsey N. Diamond, Molly Tate, Deborah F. Pinto, Bernardine M. |
| Author_xml | – sequence: 1 givenname: Carmina G. orcidid: 0000-0003-1985-2409 surname: Valle fullname: Valle, Carmina G. email: carmina.valle@unc.edu organization: Department of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill – sequence: 2 givenname: Lindsey N. surname: Camp fullname: Camp, Lindsey N. organization: Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Present address: William F. Connell School of Nursing, Boston College – sequence: 3 givenname: Molly surname: Diamond fullname: Diamond, Molly organization: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill – sequence: 4 givenname: Brooke T. surname: Nezami fullname: Nezami, Brooke T. organization: Department of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill – sequence: 5 givenname: Jessica Gokee surname: LaRose fullname: LaRose, Jessica Gokee organization: Department of Health Behavior and Policy, School of Medicine, Virginia Commonwealth University – sequence: 6 givenname: Bernardine M. surname: Pinto fullname: Pinto, Bernardine M. organization: College of Nursing, University of South Carolina – sequence: 7 givenname: Deborah F. surname: Tate fullname: Tate, Deborah F. organization: Department of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35379294$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kl1rFDEUhgep2A_9A17IgDfeTM3XJJMboRS1hYIgeh2yyZndLDPJmmQWVv-8mW5tu0VKLhLOvO9z5iTvaXXkg4eqeovROcYd_5gwRZw2iJAGccy6pn1RnWDB2oYT3B49Oh9XpymtEWJUUvaqOqYtFZJIdlL9-Q4mTi6P4HMd-noXJr-stZ2GXBvtDcQ6TXHrtiGm2vkcal1H7W0Y3W-wtQk-xzAM5Zij08OM0L4er0APeVVvVrvkTClrk93W5d2MgLgtzVzwr6uXvR4SvLnbz6qfXz7_uLxqbr59vb68uGkMRyI3pG9Zp4XVC9ppiYwAaK0RAnCPjDUEA0iCEBBkRddx2gvJGZEIqOgtSEbPqus91wa9VpvoRh13KminbgshLpWO2ZkBVKu5RhpY36PSlGGpGQVDOmu5aYlYFNanPWszLUawpkwS9XAAPfzi3Uotw1Z1ssNCiAL4cAeI4dcEKavRJQPDoD2EKSnCmSCYMEaK9P0T6TpM0ZerUkRQRCnGBD2olroM4HwfSl8zQ9UFl7IVfH73s-r8P6qyLIyuvCL0rtQPDO8eD3o_4b_oFAHZC0wMKUXo7yUYqTmfap9PVfKpbvOp2mLqnpiMy3oOQ_kdNzxvpXtrKn38EuLDbTzj-gt8IPr2 |
| CitedBy_id | crossref_primary_10_1186_s13643_024_02533_0 crossref_primary_10_1186_s40814_024_01510_7 crossref_primary_10_1200_OP_23_00171 crossref_primary_10_1089_jayao_2023_0093 crossref_primary_10_1002_casp_2786 crossref_primary_10_1002_cam4_6238 crossref_primary_10_1089_jayao_2022_0095 crossref_primary_10_1080_07853890_2024_2445184 crossref_primary_10_1016_j_apnr_2023_151686 crossref_primary_10_1080_07853890_2024_2309275 crossref_primary_10_1097_01_REO_0000000000000362 crossref_primary_10_1007_s11764_024_01577_4 crossref_primary_10_1177_27536130241305130 crossref_primary_10_1017_cts_2024_3 |
| Cites_doi | 10.1002/cncr.22102 10.1016/j.cct.2021.106285 10.1089/jayao.2017.0038 10.1007/s11764-013-0279-5 10.1002/cncr.23060 10.1089/jayao.2016.0089 10.1089/jayao.2013.0031 10.2196/12071 10.1002/pbc.27668 10.1093/jncics/pkz031 10.1093/jncics/pkaa099 10.1177/0269215521997974 10.1007/s11892-017-0938-4 10.1016/j.jbi.2008.08.010 10.1089/jayao.2015.0033 10.1016/j.cct.2021.106293 10.1016/S1470-2045(16)30215-7 10.3322/caac.21565 10.1002/cncr.26056 10.1002/cncr.32675 10.1186/1745-6215-15-326 10.1177/2055207619867223 10.1007/s11136-017-1520-x 10.1002/cncr.29669 10.3332/ecancer.2019.990 10.1111/tbj.12545 10.1016/j.ejon.2009.05.001 10.2196/jmir.7071 10.1007/s00520-008-0469-2 10.1634/theoncologist.2014-0265 10.1007/s11764-014-0348-4 10.1007/s11764-011-0173-y 10.1007/s10880-012-9317-0 10.2196/cancer.7850 10.1002/cncr.26042 10.1123/jpah.8.7.955 10.1089/jayao.2013.0021 10.1200/jco.2016.34.3_suppl.15 10.1016/j.pedhc.2012.04.010 10.1007/s12529-012-9227-4 10.1002/cncr.30935 10.1089/jayao.2011.0040 10.2196/jmir.5698 10.1016/j.invent.2016.01.001 10.1002/pbc.26497 10.1002/pbc.27426 10.1089/jayao.2018.0033 10.1186/s40814-019-0530-6 10.1177/1740774513480004 10.1111/obr.12350 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s13063-022-06148-5 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Nursing and Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1745-6215 |
| EndPage | 13 |
| ExternalDocumentID | oai_doaj_org_article_5a6a0ae4ff0548419a43ec28dd6c527b PMC8981777 A699576004 35379294 10_1186_s13063_022_06148_5 |
| Genre | Randomized Controlled Trial Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GrantInformation_xml | – fundername: National Center for Advancing Translational Sciences grantid: UL1TR002489 funderid: http://dx.doi.org/10.13039/100006108 – fundername: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill grantid: No number (University Cancer ResearchFund) funderid: http://dx.doi.org/10.13039/100008615 – fundername: National Cancer Institute grantid: R01CA204965; P30CA016086; T32CA128582 funderid: http://dx.doi.org/10.13039/100000054 – fundername: National Institute of Diabetes and Digestive and Kidney Diseases grantid: P30DK056350 funderid: http://dx.doi.org/10.13039/100000062 – fundername: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill grantid: No number (University Cancer ResearchFund) – fundername: NCATS NIH HHS grantid: UL1TR002489 – fundername: NCI NIH HHS grantid: R01 CA204965 – fundername: NCI NIH HHS grantid: T32 CA128582 – fundername: NCI NIH HHS grantid: T32CA128582 – fundername: NCI NIH HHS grantid: P30CA016086 – fundername: NIDDK NIH HHS grantid: P30DK056350 – fundername: NCI NIH HHS grantid: R01CA204965 – fundername: ; grantid: No number (University Cancer ResearchFund) – fundername: ; grantid: P30DK056350 – fundername: ; grantid: R01CA204965; P30CA016086; T32CA128582 – fundername: ; grantid: UL1TR002489 |
| GroupedDBID | --- 0R~ 123 2-G 29Q 2WC 53G 5VS 6PF 7RV 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACUHS ADBBV ADRAZ ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHYZX AIAGR ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NAPCQ O5R O5S OVT PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP WOQ WOW ~8M AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 5GY 7XB 8FK AHMBA AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS XSB 7X8 5PM |
| ID | FETCH-LOGICAL-c607t-2f548a7dab38a90c7ee5dc77e1f0cdc21ee9200e20d78863f7964290e37fde943 |
| IEDL.DBID | C6C |
| ISSN | 1745-6215 |
| IngestDate | Wed Aug 27 01:28:43 EDT 2025 Thu Aug 21 18:21:33 EDT 2025 Thu Sep 04 22:51:42 EDT 2025 Sat Jul 26 00:40:16 EDT 2025 Tue Jun 17 21:27:37 EDT 2025 Tue Jun 10 20:15:08 EDT 2025 Mon Jul 21 06:02:11 EDT 2025 Tue Jul 01 04:01:04 EDT 2025 Thu Apr 24 23:09:18 EDT 2025 Sat Sep 06 07:26:42 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Cancer survivors Recruitment methods Young adults Physical activity Cost Social media |
| Language | English |
| License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-2f548a7dab38a90c7ee5dc77e1f0cdc21ee9200e20d78863f7964290e37fde943 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0003-1985-2409 |
| OpenAccessLink | https://doi.org/10.1186/s13063-022-06148-5 |
| PMID | 35379294 |
| PQID | 2730331120 |
| PQPubID | 44365 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_5a6a0ae4ff0548419a43ec28dd6c527b pubmedcentral_primary_oai_pubmedcentral_nih_gov_8981777 proquest_miscellaneous_2647212442 proquest_journals_2730331120 gale_infotracmisc_A699576004 gale_infotracacademiconefile_A699576004 pubmed_primary_35379294 crossref_primary_10_1186_s13063_022_06148_5 crossref_citationtrail_10_1186_s13063_022_06148_5 springer_journals_10_1186_s13063_022_06148_5 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-04-04 |
| PublicationDateYYYYMMDD | 2022-04-04 |
| PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-04 day: 04 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Current controlled trials in cardiovascular medicine |
| PublicationTitleAbbrev | Trials |
| PublicationTitleAlternate | Trials |
| PublicationYear | 2022 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | L McCann (6148_CR48) 2019; 5 BM Pinto (6148_CR43) 2021; 102 D Bonner (6148_CR26) 2016; 22 G Pugh (6148_CR49) 2017; 6 C Rabin (6148_CR50) 2013; 20 LA Cadmus Bertram (6148_CR40) 2011; 8 National Cancer Policy Forum, Board on Health Care Services, A Livestrong and Institute of Medicine Workshop, Institute of Medicine (6148_CR2) 2014 LJ Bélanger (6148_CR39) 2014; 3 AS Hamilton (6148_CR24) 2019; 8 VL Hendricks-Ferguson (6148_CR51) 2013; 27 C Whitaker (6148_CR52) 2017; 19 K Thompson (6148_CR9) 2009; 13 J Topolovec-Vranic (6148_CR30) 2016; 18 SC Sodergren (6148_CR7) 2017; 26 ED Seltzer (6148_CR53) 2014; 8 ES Zhou (6148_CR41) 2013; 10 KM Sturgeon (6148_CR42) 2018; 124 L Keaver (6148_CR23) 2019; 5 A Bleyer (6148_CR18) 2006; 107 C Rabin (6148_CR28) 2013; 20 V Forcina (6148_CR20) 2018; 9 R Kayrouz (6148_CR55) 2016; 4 C Benedict (6148_CR32) 2018; 7 6148_CR11 LC Harlan (6148_CR25) 2011; 5 C Rabin (6148_CR36) 2011; 1 PC Nathan (6148_CR10) 2011; 117 CG Valle (6148_CR33) 2013; 7 C Rabin (6148_CR37) 2016; 5 6148_CR47 DJ Moke (6148_CR14) 2019; 3 6148_CR46 CL Collins (6148_CR16) 2015; 121 B Zebrack (6148_CR8) 2009; 17 CG Valle (6148_CR31) 2021; 103 N Bhakta (6148_CR4) 2016; 17 K Ambrose (6148_CR5) 2016; 34 SJ Nass (6148_CR3) 2015; 20 C Benedict (6148_CR27) 2019; 5 BJ Zebrack (6148_CR6) 2011; 117 E Lam (6148_CR29) 2016; 17 6148_CR38 HM Parsons (6148_CR17) 2019; 66 SC Adams (6148_CR12) 2021; 5 DF Tate (6148_CR54) 2014; 15 EJ Siembida (6148_CR19) 2020; 126 6148_CR35 6148_CR1 NJ Hulbert-Williams (6148_CR21) 2019; 13 PA Harris (6148_CR34) 2009; 42 JR Gorman (6148_CR22) 2014; 3 A Lanoye (6148_CR45) 2017; 17 A Wurz (6148_CR44) 2019; 5 ME Burke (6148_CR15) 2007; 110 MM Fidler (6148_CR13) 2019; 66 |
| References_xml | – volume: 107 start-page: 1645 issue: 7 Suppl year: 2006 ident: 6148_CR18 publication-title: Cancer. doi: 10.1002/cncr.22102 – volume: 102 start-page: 106285 year: 2021 ident: 6148_CR43 publication-title: Contemp Clin Trials doi: 10.1016/j.cct.2021.106285 – volume: 7 start-page: 103 issue: 1 year: 2018 ident: 6148_CR32 publication-title: J Adolesc Young Adult Oncol doi: 10.1089/jayao.2017.0038 – volume: 7 start-page: 355 issue: 3 year: 2013 ident: 6148_CR33 publication-title: J Cancer Surviv doi: 10.1007/s11764-013-0279-5 – volume: 110 start-page: 2385 issue: 11 year: 2007 ident: 6148_CR15 publication-title: Cancer. doi: 10.1002/cncr.23060 – volume: 6 start-page: 318 issue: 2 year: 2017 ident: 6148_CR49 publication-title: J Adolesc Young Adult Oncol doi: 10.1089/jayao.2016.0089 – volume: 3 start-page: 59 issue: 2 year: 2014 ident: 6148_CR22 publication-title: J Adolesc Young Adult Oncol doi: 10.1089/jayao.2013.0031 – volume: 5 start-page: e12071 issue: 2 year: 2019 ident: 6148_CR48 publication-title: JMIR Cancer doi: 10.2196/12071 – volume: 66 start-page: e27668 issue: 6 year: 2019 ident: 6148_CR13 publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.27668 – volume: 3 start-page: pkz031 issue: 2 year: 2019 ident: 6148_CR14 publication-title: JNCI Cancer Spectr doi: 10.1093/jncics/pkz031 – volume: 5 start-page: pkaa099 issue: 1 year: 2021 ident: 6148_CR12 publication-title: JNCI Cancer Spectr doi: 10.1093/jncics/pkaa099 – ident: 6148_CR47 – ident: 6148_CR38 doi: 10.1177/0269215521997974 – volume: 17 start-page: 114 issue: 11 year: 2017 ident: 6148_CR45 publication-title: Curr Diab Rep doi: 10.1007/s11892-017-0938-4 – volume: 42 start-page: 377 issue: 2 year: 2009 ident: 6148_CR34 publication-title: J Biomed Inform doi: 10.1016/j.jbi.2008.08.010 – volume: 5 start-page: 41 issue: 1 year: 2016 ident: 6148_CR37 publication-title: J Adolesc Young Adult Oncol doi: 10.1089/jayao.2015.0033 – volume: 103 start-page: 106293 year: 2021 ident: 6148_CR31 publication-title: Contemp Clin Trials doi: 10.1016/j.cct.2021.106293 – volume: 17 start-page: 1325 issue: 9 year: 2016 ident: 6148_CR4 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)30215-7 – ident: 6148_CR1 doi: 10.3322/caac.21565 – volume: 117 start-page: 2289 issue: 10 Suppl year: 2011 ident: 6148_CR6 publication-title: Cancer. doi: 10.1002/cncr.26056 – volume: 126 start-page: 949 issue: 5 year: 2020 ident: 6148_CR19 publication-title: Cancer. doi: 10.1002/cncr.32675 – volume: 15 start-page: 326 year: 2014 ident: 6148_CR54 publication-title: Trials. doi: 10.1186/1745-6215-15-326 – volume: 5 start-page: 205520761986722 year: 2019 ident: 6148_CR27 publication-title: Digit Health doi: 10.1177/2055207619867223 – volume: 26 start-page: 1659 issue: 7 year: 2017 ident: 6148_CR7 publication-title: Qual Life Res doi: 10.1007/s11136-017-1520-x – volume: 121 start-page: 4398 issue: 24 year: 2015 ident: 6148_CR16 publication-title: Cancer. doi: 10.1002/cncr.29669 – ident: 6148_CR46 – volume: 13 start-page: 990 year: 2019 ident: 6148_CR21 publication-title: Ecancermedicalscience. doi: 10.3332/ecancer.2019.990 – volume: 22 start-page: 166 issue: 2 year: 2016 ident: 6148_CR26 publication-title: Breast J doi: 10.1111/tbj.12545 – volume: 13 start-page: 207 issue: 3 year: 2009 ident: 6148_CR9 publication-title: Eur J Oncol Nurs doi: 10.1016/j.ejon.2009.05.001 – volume: 19 start-page: e290 issue: 8 year: 2017 ident: 6148_CR52 publication-title: J Med Internet Res doi: 10.2196/jmir.7071 – volume: 17 start-page: 349 issue: 4 year: 2009 ident: 6148_CR8 publication-title: Support Care Cancer doi: 10.1007/s00520-008-0469-2 – volume: 20 start-page: 186 issue: 2 year: 2015 ident: 6148_CR3 publication-title: Oncologist. doi: 10.1634/theoncologist.2014-0265 – ident: 6148_CR35 – volume: 8 start-page: 349 issue: 3 year: 2014 ident: 6148_CR53 publication-title: J Cancer Surviv doi: 10.1007/s11764-014-0348-4 – volume: 5 start-page: 305 issue: 3 year: 2011 ident: 6148_CR25 publication-title: J Cancer Surviv doi: 10.1007/s11764-011-0173-y – volume: 20 start-page: 33 issue: 1 year: 2013 ident: 6148_CR28 publication-title: J Clin Psychol Med Settings doi: 10.1007/s10880-012-9317-0 – volume: 5 start-page: e7850 issue: 1 year: 2019 ident: 6148_CR23 publication-title: JMIR Cancer doi: 10.2196/cancer.7850 – volume: 117 start-page: 2335 issue: 10 Suppl year: 2011 ident: 6148_CR10 publication-title: Cancer. doi: 10.1002/cncr.26042 – volume: 8 start-page: 955 issue: 7 year: 2011 ident: 6148_CR40 publication-title: J Phys Act Health doi: 10.1123/jpah.8.7.955 – volume: 3 start-page: 83 issue: 2 year: 2014 ident: 6148_CR39 publication-title: J Adolesc Young Adult Oncol doi: 10.1089/jayao.2013.0021 – volume: 34 start-page: 15 issue: 3_suppl year: 2016 ident: 6148_CR5 publication-title: J Clin Oncol doi: 10.1200/jco.2016.34.3_suppl.15 – volume: 27 start-page: 434 issue: 6 year: 2013 ident: 6148_CR51 publication-title: J Pediatr Health Care doi: 10.1016/j.pedhc.2012.04.010 – volume-title: Identifying and addressing the needs of adolescents and young adults with cancer: workshop summary year: 2014 ident: 6148_CR2 – volume: 20 start-page: 304 issue: 2 year: 2013 ident: 6148_CR50 publication-title: Int J Behav Med doi: 10.1007/s12529-012-9227-4 – volume: 124 start-page: 95 issue: 1 year: 2018 ident: 6148_CR42 publication-title: Cancer. doi: 10.1002/cncr.30935 – volume: 9 start-page: 87 year: 2018 ident: 6148_CR20 publication-title: Adolesc Health Med Ther – volume: 1 start-page: 188 issue: 4 year: 2011 ident: 6148_CR36 publication-title: J Adolesc Young Adult Oncol doi: 10.1089/jayao.2011.0040 – volume: 18 start-page: e286 issue: 11 year: 2016 ident: 6148_CR30 publication-title: J Med Internet Res doi: 10.2196/jmir.5698 – volume: 4 start-page: 1 year: 2016 ident: 6148_CR55 publication-title: Internet Interv doi: 10.1016/j.invent.2016.01.001 – ident: 6148_CR11 doi: 10.1002/pbc.26497 – volume: 66 start-page: e27426 issue: 1 year: 2019 ident: 6148_CR17 publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.27426 – volume: 8 start-page: 40 issue: 1 year: 2019 ident: 6148_CR24 publication-title: J Adolesc Young Adult Oncol doi: 10.1089/jayao.2018.0033 – volume: 5 start-page: 154 year: 2019 ident: 6148_CR44 publication-title: Pilot Feasibility Stud doi: 10.1186/s40814-019-0530-6 – volume: 10 start-page: 587 issue: 4 year: 2013 ident: 6148_CR41 publication-title: Clin Trials doi: 10.1177/1740774513480004 – volume: 17 start-page: 178 issue: 2 year: 2016 ident: 6148_CR29 publication-title: Obes Rev doi: 10.1111/obr.12350 |
| SSID | ssj0043934 ssj0017864 |
| Score | 2.3835595 |
| Snippet | Purpose
Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study... Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study describes... Purpose Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study... PurposeFew studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This study... Abstract Purpose Few studies have recruited young adult cancer survivors (YACS) from around the USA into remotely-delivered behavioral clinical trials. This... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 254 |
| SubjectTerms | Adolescent Adult Biomedicine Cancer Survivors Cancer therapies Chronic illnesses Clinical trials Consent Cost Costs Demographic aspects Ethnicity Exercise Female Health aspects Health Sciences Humans Intervention Male Medicine Medicine & Public Health Methods Minority Groups Neoplasms - therapy Patient Selection Physical activity Physical fitness Recruiting Recruitment methods Social media Social networks Statistics for Life Sciences Telemedicine Young Adult Young adults |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxUxFA7ShbgR306tEkFwoUMzk_eyiqUIdWWhu5BJMnihnSn3Iah_3nMyDzsVdePucpMJyXmHnPMdQl6xJmkrgywZl6YUvLGlN6YqI4Tm3LTemwyxcfpJnZyJj-fy_FqrL8wJG-CBB8IdSq8880m0LQQXRlTWC55CbWJUQda6QesLbmy6TA02GLwsF1OJjFGHG7DU-b2yxk4GwpRy4YYyWv_vNvmaU7qZMHnj1TQ7o-N75O4YRdKjYff3ya3UPSC3T8d38ofkB0aDu1XOIKd9S7-hTtOMtUED8nlNNzswEl_79Yauum1PPQWnFfvL1fcU6Zi_fgE_c1cPXMJ39HKoWaJXI28pFkVg7wlcYs6cfETOjj98fn9Sjm0WyqCY3pZ1C4T1OvqGG29Z0CnJGLROVctCDHWVkgVdSjWLcF9WvMXq1dqyxHUbkxX8Mdnr-i49JbQVKUTsoh6ZEBa4E4XgmtlGS7ADqi5INVHdhRGDHFthXLh8FzHKDZxywCmXOeVkQd7M31wNCBx_nf0OmTnPRPTs_AfIlBtlyv1LpgryGkXBoY7D9oIfSxXgkIiW5Y6UtRJfNEVBDhYzQTfDcngSJjfaho2DgJFxDnEuK8jLeRi_xHy3LvU7mIOo_hh6AcmeDLI3H4lLriGohcX1QioXZ16OdKsvGTncWFNprQvydpLfX9v6M033_wdNn5E7ddY_zHs6IHvb9S49h3hu27zIqvsTuF9GUQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1ba9UwOOgE8UW8rzolguCDlqVN0iRPMsUxhPnk4LyFNEn1wNYez0VQ_7zfl5PT2Yl7K82FJN81-W6EvGJtVEZ6WTIudSl4a0qndVUGUM257pzTKcXG6efm5Ex8mslZfnBbZbfKHU9MjDoMHt_ID0HMMs5BO2DvFt9LrBqF1tVcQuMmuVWBqoJYrWbjhatSuhG7QBndHK6AXyerZY31DIQu5UQYpZz9_3Lmv0TTVbfJK7bTJJKO75G7WZekR1vg3yc3Yv-A3D7N1vKH5DfqhJt58iOnQ0d_ImXTlHGDeoT2kq42wCp-DMsVnffrgToKoisMF_NfMdDsxX4On6m2B07henqxjVyiiwxhiqERWIECpxj9Jx-Rs-OPXz6clLnYQukbptZl3cHdxangWq6dYV7FKINXKlYd88HXVYwGKCrWLMCtueEdxrDWhkWuuhCN4I_JXj_0cZ_QTkQfsJZ6YEKYWrVBCK6YaZUEbtDUBal2p259zkSOBTHObbqR6MZuIWUBUjZBysqCvBnHLLZ5OK7t_R6BOfbEHNrpx7D8ajNJWukax1wUXQdqqxaVcYJHX-sQGi9h1QV5jahgkdJhed7lgAXYJObMskeNMRLtmqIgB5OeQKF-2rxDJps5xMpe4nNBXo7NOBK93vo4bKAP5vZHBQyO7MkW98YtcckVYDxMriZYOdnztKWff0v5w7XRlVKqIG93-Hu5rP-f6dPrd_GM3KkTZaFf0wHZWy838Tnoa-v2RSLKP8ryPT8 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1Ni9UwMKwriBfx2-oqEQQPWk2bpEkOIqu4LMLz5MLeQpqk-uBtu74PcfXPO5PXVruugrfSTEKSmcnMMF-EPGF1VEZ6mTMudS54bXKndZEHUM25bpzTqcTG7EN1eCTeH8vjHTK0O-ovcHWhaYf9pI6Wixffvpy9BoZ_lRheVy9X8A4nb2SJfQqEzuUlchkkU4lUPhOjVwFkLxdD4syF8ybCKdXw__Ol_k1UnQ-jPOdLTSLq4Dq51uuWdH9LDDfITmxvkiuz3nt-i_xAHXEzT3HltGvoGXI6TRU4qEfsL-lqA0_H1265ovN23VFHQZSF7mT-PQbaR7Uv4DP1-sAlXEtPtplM9LTHOMVUCexIgUuM8ZS3ydHBu49vD_O--ULuK6bWedmALeNUcDXXzjCvYpTBKxWLhvngyyJGAxwWSxbAiq54gzmtpWGRqyZEI_gdstt2bbxHaCOiD9hbPTAhTKnqIARXzNRKwutQlRkphlu3vq9Mjg0yFjZZKLqyW0xZwJRNmLIyI8_GOafbuhz_hH6DyBwhsaZ2-tEtP9meRa10lWMuiqYBNVaLwjjBoy91CJWXsOuMPEVSsEiLsD3v-gQGOCTW0LL7lTES_ZwiI3sTSOBYPx0eiMkOBG9BjWScg_bLMvJ4HMaZGAXXxm4DMFjrHxUyuLK7W9obj8QlV6DqwuJqQpWTM09H2vnnVE9cG10opTLyfKDfX9v6-53e_z_wB-RqmTgN4572yO56uYkPQZ9b148Sk_4Efy1EwQ priority: 102 providerName: Scholars Portal |
| Title | Recruitment of young adult cancer survivors into a randomized controlled trial of an mHealth physical activity intervention |
| URI | https://link.springer.com/article/10.1186/s13063-022-06148-5 https://www.ncbi.nlm.nih.gov/pubmed/35379294 https://www.proquest.com/docview/2730331120 https://www.proquest.com/docview/2647212442 https://pubmed.ncbi.nlm.nih.gov/PMC8981777 https://doaj.org/article/5a6a0ae4ff0548419a43ec28dd6c527b |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: RBZ dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017864 issn: 1745-6215 databaseCode: KQ8 dateStart: 20000101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: KQ8 dateStart: 20060101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: ABDBF dateStart: 20060101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: DIK dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017864 issn: 1745-6215 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: Medline (PubMed) customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: RPM dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: BENPR dateStart: 20000401 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection (NC LIVE) customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: 7X7 dateStart: 20000401 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1745-6215 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: M48 dateStart: 20060401 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: AAJSJ dateStart: 20000401 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: C6C dateStart: 20000401 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: U2A dateStart: 20000401 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3bahQxNNgWxBfx7mhdIgg-6GBmkkySx21pLQtbRF3Yt5BNMrjQzpS9COrPe052du3UC_iSGSYnIcm55GRyLoS8YrOojPQyZ1zqXPCZyZ3WRR5ANee6dk6nEBvj8-psIkZTOe3C5KAvzPX7-0JX75YgY9NNY4k5CITO5R45kPARzfeOq-Ot1IV9lYutU8wf2_U2nhSf_3cpfG0bumkieeOeNG0_p_fI3U5vpMMNou-TW7F5QG6Pu5vxh-QH6n_rebIZp21NvyEX0xRdg3rE7IIu1yAWvraLJZ03q5Y6CttUaC_n32OgncX6BbymPB7YhWvo5cZLiV512KToBoHZJrCLna3kIzI5Pfl8fJZ3iRVyXzG1yssazilOBTfj2hnmVYwyeKViUTMffFnEaIB7YskCnJArXqO_amlY5KoO0Qj-mOw3bROfElqL6APmTQ9MCFOqWRCCK2ZmSgLnV2VGiu2qW99FHcfkFxc2nT50ZTeYsoApmzBlZUbe7NpcbWJu_BP6CJG5g8R42ekDkJHt2M9KVznmoqhrUFG1KIwTPPpSh1B5CaPOyGskBYtcDcPzrnNOgElifCw7rIyReIcpMnLYgwRu9P3qLTHZThosLaiIjHPQbFlGXu6qsSVauDWxXQMMxvFHZQuW7MmG9nZT4pIrUGOhc9Wjyt6c-zXN_EuKFa6NLpRSGXm7pd9fw_r7mj77P_Dn5E6ZOA1tmg7J_mqxji9AV1vNBmRPTdWAHAyHo08jeB6dnH_4OEisO0j_P6B8Py2gHAsN5aQc_gTqaj3m |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4lkCBYwE4gBRk9iJnQNC5VFtabenVtqbcWwHVmqTZR-gwn_iNzLjPEqK6K23KHYs2zOeGWceHyHPo8KJPDVpGLFUhpwVeailjEMLpjmTpdbSl9gYH2SjI_5pkk7WyO8uFwbDKjuZ6AW1rQ3-I98CNRsxBtZB9Hb2LUTUKPSudhAaDVvsudMfcGVbvNn9APR9kSQ7Hw_fj8IWVSA0WSSWYVKCka6F1QWTOo-McC61RggXl5GxJomdy4F1XBJZuB5mrMRkzSSPHBOldTlnMO4VcpWziGOtfjHpL3ixkBnvEnNktrUA_eC9pAniJ3AZpgPl5zEC_tUEf6nC82Ga53y1XgXu3CI3W9uVbjfMdpusueoOuTZuvfN3yS-0QVdTH7dO65KeoiShvsIHNchdc7pYgWj6Xs8XdFota6opqEpbn0x_OkvbqPljePRYIjiEruhJkylFZy1HUUzFQMQLHKKP17xHji6FDPfJelVX7gGhJXfGIna7BZLkiSgs50xEeSFSkD5ZEpC423Vl2srnCMBxrPwNSGaqoZQCSilPKZUG5FX_zayp-3Fh73dIzL4n1uz2L-r5F9WKAJXqTEfa8bIEM1nyONecOZNIazOTwqwD8hJZQaFkgekZ3SZIwCKxRpfazvI8RT8qD8jmoCdIBDNs7phJtRJpoc7OT0Ce9c34JUbZVa5eQR_EEkCDD7Zso-G9fkksZQJMaRhcDLhysOZhSzX96uuVy1zGQoiAvO7492xa_9_Thxev4im5Pjoc76v93YO9R-RG4k8ZxlRtkvXlfOUeg624LJ74A0rJ58uWCH8AZQh6bQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouiHcDBYwE4gDRJrETOweECmXVUlpxoNLejGM7sFKbLPsAFf4Zv44Z51FSRG-9RbFjeTzjb8bxPAh5GhVO5KlJw4ilMuSsyEMtZRxaMM2ZLLWWPsXGwWG2e8TfT9LJGvndxcKgW2WHiR6obW3wH_kI1GzEGFgH0ahs3SI-7oxfz76FWEEKb1q7chqNiOy70x9wfFu82tsBXj9LkvG7T293w7bCQGiySCzDpASDXQurCyZ1HhnhXGqNEC4uI2NNEjuXgxi5JLJwVMxYiYGbSR45Jkrrcs5g3CvkqmBAF-wlMekPe7GQGe-CdGQ2WoCu8DemCdZS4DJMB4rQ1wv4Vyv8pRbPu2yeu7f16nB8g1xv7Vi63QjeTbLmqltk46C9qb9NfqE9upp6H3Zal_QUUYX6bB_UoKTN6WIFMPW9ni_otFrWVFNQm7Y-mf50lrYe9Mfw6OuK4BC6oidN1BSdtdJFMSwDq1_gEL3v5h1ydClsuEvWq7pym4SW3BmLddxtxHmeiMJyzkSUFyIFJMqSgMTdqivTZkHHYhzHyp-GZKYaTinglPKcUmlAXvTfzJocIBf2foPM7Hti_m7_op5_US0cqFRnOtKOlyWYzJLHuebMmURam5kUZh2Q5ygKClEGpmd0GywBRGK-LrWd5XmKd6o8IFuDnoAOZtjcCZNq0WmhzvZSQJ70zfgletxVrl5BH6wrgMYfLNm9RvZ6kljKBJjVMLgYSOWA5mFLNf3qc5fLXMZCiIC87OT3bFr_X9P7F1PxmGwAFqgPe4f7D8i1xG8ydK_aIuvL-co9BLNxWTzy-5OSz5cNCH8AQYp-qA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recruitment+of+young+adult+cancer+survivors+into+a+randomized+controlled+trial+of+an+mHealth+physical+activity+intervention&rft.jtitle=Trials&rft.au=Valle%2C+Carmina+G.&rft.au=Camp%2C+Lindsey+N.&rft.au=Diamond%2C+Molly&rft.au=Nezami%2C+Brooke+T.&rft.date=2022-04-04&rft.pub=BioMed+Central&rft.eissn=1745-6215&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs13063-022-06148-5&rft.externalDocID=10_1186_s13063_022_06148_5 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-6215&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-6215&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-6215&client=summon |